D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.29B |
| 2 |
Apple
AAPL
|
$1.22B |
| 3 |
T-Mobile US
TMUS
|
$889M |
| 4 |
Micron Technology
MU
|
$887M |
| 5 |
Netflix
NFLX
|
$828M |
Top Sells
| 1 |
Robinhood
HOOD
|
$1.02B |
| 2 |
GE Vernova
GEV
|
$976M |
| 3 |
Charles Schwab
SCHW
|
$582M |
| 4 |
TSMC
TSM
|
$572M |
| 5 |
Microsoft
MSFT
|
$564M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 12.06% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Financials | 9.02% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Monster Beverage
MNST
$61.5B
| $63.9M | 0.05% |
1,019,427
+61,643
| +6% | +$3.86M |
|
277
Vertiv
VRT
$46.5B
| $63.7M | 0.05% |
496,248
+9,792
| +2% | +$1.26M |
|
278
Rio Tinto
RIO
$104B
| $63.5M | 0.05% |
1,087,779
+527,466
| +94% | +$30.8M |
|
279
Groupon
GRPN
$920M
| $63.4M | 0.05% |
1,896,242
+1,381,886
| +269% | +$46.2M |
|
280
S&P Global
SPGI
$167B
| $63.3M | 0.04% |
120,053
+100,588
| +517% | +$53M |
|
281
Mobileye
MBLY
$12.1B
| $62.5M | 0.04% |
3,476,566
+1,667,983
| +92% | +$30M |
|
282
Check Point Software Technologies
CHKP
$21.1B
| $62.4M | 0.04% |
282,129
+97,879
| +53% | +$21.7M |
|
283
H&R Block
HRB
$6.97B
| $62.3M | 0.04% |
1,134,593
+172,575
| +18% | +$9.47M |
|
284
West Pharmaceutical
WST
$18.2B
| $62.2M | 0.04% |
284,336
+181,314
| +176% | +$39.7M |
|
|
KKR.PRD
285
KKR & Co. Inc. 6.25% Series D Mandatory Convertible Preferred Stock
KKR.PRD
$2.83B
| $61.8M | 0.04% |
1,154,000
-646,000
| -36% | -$34.6M |
|
286
Aon
AON
$79.8B
| $61.7M | 0.04% |
172,969
+91,041
| +111% | +$32.5M |
|
287
Riot Platforms
RIOT
$4.97B
| $61.6M | 0.04% |
5,455,200
-1,270,463
| -19% | -$14.4M |
|
288
Altria Group
MO
$110B
| $61.4M | 0.04% |
1,047,733
+421,910
| +67% | +$24.7M |
|
289
Aflac
AFL
$56.9B
| $61.4M | 0.04% |
582,082
+505,908
| +664% | +$53.4M |
|
290
BioMarin Pharmaceuticals
BMRN
$10.8B
| $61.3M | 0.04% |
1,115,428
+569,653
| +104% | +$31.3M |
|
291
Woodward
WWD
$14.4B
| $61.2M | 0.04% |
249,841
+246,255
| +6,867% | +$60.4M |
|
292
Teleflex
TFX
$5.75B
| $60.9M | 0.04% |
514,730
-14,485
| -3% | -$1.71M |
|
293
DraftKings
DKNG
$23B
| $60.9M | 0.04% |
1,420,355
-942,600
| -40% | -$40.4M |
|
294
iShares China Large-Cap ETF
FXI
$6.74B
| $60.6M | 0.04% |
1,649,685
+1,111,852
| +207% | +$40.9M |
|
295
Adient
ADNT
$1.99B
| $60.5M | 0.04% |
3,110,355
+569,320
| +22% | +$11.1M |
|
296
CME Group
CME
$94.6B
| $60.3M | 0.04% |
218,937
-93,891
| -30% | -$25.9M |
|
297
Iron Mountain
IRM
$27.3B
| $59.9M | 0.04% |
583,977
-233,469
| -29% | -$23.9M |
|
298
Sherwin-Williams
SHW
$93.6B
| $59.8M | 0.04% |
174,202
-439,671
| -72% | -$151M |
|
299
Thomson Reuters
TRI
$78.2B
| $59.5M | 0.04% |
295,940
+103,939
| +54% | +$20.9M |
|
300
3M
MMM
$82B
| $58.7M | 0.04% |
385,544
-242,586
| -39% | -$36.9M |
|